HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Michael D Hill Selected Research

Tissue Plasminogen Activator (Alteplase)

12/2015Minimal sufficient balance-a new strategy to balance baseline covariates and preserve randomness of treatment allocation.
12/2015Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data.
11/2015Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions.
9/2015Accuracy of the ABC/2 Score for Intracerebral Hemorrhage: Systematic Review and Analysis of MISTIE, CLEAR-IVH, and CLEAR III.
8/2015Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke.
8/2015Intraventricular fibrinolysis with tissue plasminogen activator is associated with transient cerebrospinal fluid inflammation: a randomized controlled trial.
6/2015Response to letter regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion".
6/2015Symptomatic intracranial hemorrhage in the ALIAS Multicenter Trial: relationship to endovascular thrombolytic therapy.
5/2015Differential Effect of Baseline Computed Tomographic Angiography Collaterals on Clinical Outcome in Patients Enrolled in the Interventional Management of Stroke III Trial.
5/2015Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Michael D Hill Research Topics

Disease

104Stroke (Strokes)
12/2015 - 01/2002
11Hemorrhage
09/2015 - 11/2003
11Hypertension (High Blood Pressure)
05/2015 - 05/2006
9Cerebral Hemorrhage
09/2015 - 11/2003
8Thrombosis (Thrombus)
04/2015 - 09/2003
8Kidney Diseases (Kidney Disease)
05/2012 - 05/2006
7Myocardial Infarction
06/2011 - 02/2004
5Intracranial Hemorrhages (Intracranial Hemorrhage)
11/2015 - 07/2013
5Body Weight (Weight, Body)
05/2010 - 05/2006
5Diabetes Mellitus
05/2010 - 05/2006
5Albuminuria
05/2010 - 05/2006
5Heart Failure
05/2009 - 05/2006
4Atrial Fibrillation
05/2012 - 07/2004
3Transient Ischemic Attack
04/2015 - 01/2005
2Infarction
12/2015 - 01/2011
2Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
08/2015 - 10/2014
2Renal Artery Obstruction (Renal Artery Stenosis)
05/2015 - 07/2011
2Cranial Nerve Injuries
05/2015 - 09/2011
2Coronary Artery Disease (Coronary Atherosclerosis)
05/2014 - 05/2010
2Myocardial Ischemia (Ischemic Heart Diseases)
05/2014 - 05/2009
2Cardiovascular Diseases (Cardiovascular Disease)
07/2011 - 05/2006
2Pathologic Constriction (Stenosis)
01/2009 - 01/2007
1Inflammation
08/2015
1Multiple Sclerosis
08/2014
1Cerebral Infarction
06/2014
1Post-Concussion Syndrome
01/2014
1Brain Injuries (Brain Injury)
01/2014
1Hyperuricemia
08/2013
1Aneurysm (Aneurysms)
11/2012
1Systolic Heart Failure
05/2012
1Hypotension (Low Blood Pressure)
02/2012
1Neurologic Manifestations (Neurological Manifestations)
01/2012

Drug/Important Bio-Agent (IBA)

47Tissue Plasminogen Activator (Alteplase)FDA Link
12/2015 - 01/2002
14glucuronyl glucosamine glycan sulfate (Vessel)IBA
11/2015 - 02/2004
9Glucose (Dextrose)FDA LinkGeneric
01/2014 - 11/2005
7Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
07/2011 - 05/2006
6Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2014 - 02/2004
61,4-dihydropyridine (dihydropyridine)IBA
07/2011 - 05/2006
6Angiotensin Receptor AntagonistsIBA
07/2011 - 05/2006
6CholesterolIBA
05/2010 - 05/2006
6Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2010 - 11/2005
5ThiazidesIBA
05/2010 - 05/2006
4Fibrinolytic Agents (Antithrombotic Agents)IBA
04/2015 - 03/2004
4Dietary SodiumIBA
05/2010 - 05/2007
4Calcium Channel Blockers (Blockers, Calcium Channel)IBA
05/2009 - 05/2006
3Warfarin (Coumadin)FDA LinkGeneric
11/2015 - 07/2004
3clopidogrel (Plavix)FDA Link
10/2013 - 01/2005
3recombinant FVIIa (rFVIIa)IBA
11/2008 - 01/2006
2Cytidine Triphosphate (CTP)IBA
12/2015 - 09/2015
2Vitamin KFDA Link
11/2015 - 02/2011
2tenecteplaseFDA Link
06/2015 - 03/2015
2Heparinoids (Heparinoid)IBA
03/2015 - 01/2012
2FibrinIBA
03/2015 - 09/2008
2TroponinIBA
01/2015 - 06/2011
2Blood Glucose (Blood Sugar)IBA
06/2014 - 02/2012
2Hemoglobins (Hemoglobin)IBA
05/2014 - 05/2010
2Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
04/2014 - 05/2010
2ErythropoietinFDA Link
04/2014 - 05/2010
2AnticoagulantsIBA
07/2013 - 11/2008
2AngiotensinsIBA
05/2012 - 05/2009
2Biological Markers (Surrogate Marker)IBA
06/2011 - 11/2005
2Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
05/2010 - 05/2007
2NitrendipineIBA
05/2009 - 02/2006
2eprosartan (Teveten)FDA Link
05/2009 - 02/2006
2Factor VIIa (Activated Factor VII)IBA
03/2007 - 01/2006
2DiureticsIBA
08/2006 - 11/2005
1Captopril (Capoten)FDA LinkGeneric
12/2015
1PlasminogenIBA
08/2015
1Desmodus rotundus salivary plasminogen activator alpha 1IBA
06/2015
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
04/2015
1boldenone undecylenate (Equipoise)IBA
01/2015
1GadoliniumIBA
08/2014
1SodiumIBA
05/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2014
1Epoetin Alfa (Epogen)FDA Link
04/2014
1Fibrinogen (Factor I)FDA Link
01/2014
1fibrin fragment D (D-dimer)IBA
01/2014
1MelatoninIBA
01/2014
1Uric Acid (Urate)IBA
08/2013
1diazonaphthalenedisulfonic acid (NDS)IBA
11/2012
1Contrast MediaIBA
06/2012
1A-factor (Streptomyces)IBA
05/2012
1Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
05/2012
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2012
1Heparin (Liquaemin)FDA LinkGeneric
01/2012
1danaproid (danaparoid)FDA Link
01/2012

Therapy/Procedure

11Thrombolytic Therapy
06/2015 - 02/2004
8Endarterectomy (Thromboendarterectomy)
05/2015 - 11/2003
7Thrombectomy
10/2015 - 01/2011
7Carotid Endarterectomy
05/2015 - 11/2003
3General Anesthesia
08/2015 - 02/2012
3Angioplasty (Angioplasty, Transluminal)
05/2015 - 09/2003
2Local Anesthesia
08/2015 - 02/2012
2Stents
08/2015 - 09/2011
2Endovascular Procedures
06/2014 - 11/2012
2Drug Therapy (Chemotherapy)
05/2014 - 05/2009
2Intravenous Infusions
11/2012 - 08/2007
2Length of Stay
08/2012 - 01/2009
1Embolectomy
04/2012
1Early Ambulation
01/2012